| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | RM16A4BA8R |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | B-lymphocyte antigen CD19 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Anemia, Hemolytic, Autoimmune | 3 | D000744 | ClinicalTrials |
| Immunoglobulin G4-Related Disease | 3 | D000077733 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298134 |
| FDA SRS | RM16A4BA8R |
CONTENTS